BST:0JS

Stock Analysis Report

Executive Summary

MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States.

Snowflake

Fundamentals

Imperfect balance sheet with limited growth.


Similar Companies

Share Price & News

How has MedMen Enterprises's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

0JS

3.6%

DE Pharmaceuticals

2.8%

DE Market


1 Year Return

n/a

0JS

-1.8%

DE Pharmaceuticals

2.9%

DE Market


Share holder returns

0JSIndustryMarket
7 Day0%3.6%2.8%
30 Day0%-0.2%-0.2%
90 Day0%10.8%0.9%
1 Yearn/a1.5%-1.8%6.2%2.9%
3 Yearn/a-5.8%-13.7%18.2%8.0%
5 Yearn/a-2.4%-14.4%43.1%23.6%

Price Volatility Vs. Market

How volatile is MedMen Enterprises's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is MedMen Enterprises undervalued based on future cash flows and its price relative to the stock market?

1.38x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Information is not available.

Information is not available.


Price Based on Earnings

Information is not available.

Information is not available.


Price Based on Expected Growth

Information is not available.


Price Based on Value of Assets

Information is not available.


Next Steps

Future Growth

How is MedMen Enterprises expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

2.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Information is not available.

Information is not available.

High Growth Earnings: 0JS is forecast to remain unprofitable over the next 3 years.

Information is not available.

Information is not available.


Earnings per Share Growth Estimates


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has MedMen Enterprises performed over the past 5 years?

-528.3%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Information is not available.

Information is not available.

Information is not available.


Return on Equity

Information is not available.


Return on Assets

Information is not available.


Return on Capital Employed

Information is not available.


Next Steps

Financial Health

How is MedMen Enterprises's financial position?


Financial Position Analysis

Information is not available.

Information is not available.


Debt to Equity History and Analysis

Information is not available.

Information is not available.


Balance Sheet

Information is not available.

Information is not available.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Information is not available.

Information is not available.


Next Steps

Dividend

What is MedMen Enterprises's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.9%industryaverage2.3%forecastin3Yearsn/a

Current dividend yield vs market & industry


Dividend Yield and Payments Analysis

Information is not available.

Information is not available.

Stable Dividend: Insufficient data to determine if 0JS's dividends per share have been stable in the past.

Information is not available.


Current Payout to Shareholders

Information is not available.


Future Payout to Shareholders

Information is not available.


Next Steps

Management

What is the CEO of MedMen Enterprises's salary, the management and board of directors tenure and is there insider trading?

0.8yrs

Average management tenure


CEO

Adam Bierman (37yo)

1.1yrs

Tenure

0

Mr. Adam Bierman is Co-Founder of MedMen Enterprises Inc. and serves as Chief Executive Officer. Mr. Bierman serves as Director at MedMen Enterprises Inc. since May 28, 2018. He is a Co Founder and Chief E ...


Management Age and Tenure

0.8yrs

Average Tenure

47.5yo

Average Age

Information is not available.


Board Age and Tenure

0.8yrs

Average Tenure

52yo

Average Age

Information is not available.


Insider Trading

Information is not available.


Recent Insider Transactions

BuyUS$482,43302 Oct 19
Chris Ganan
EntityIndividual
Shares265,592
Max PriceUS$1.82
BuyUS$363,33204 Sep 19
Andrew Modlin
EntityIndividual
Role
Member of the Board of Directors
Co-Founder
Shares198,018
Max PriceUS$1.85
BuyUS$21,27117 Dec 18
Andrew Modlin
EntityIndividual
Role
Member of the Board of Directors
Co-Founder
Shares6,845
Max PriceUS$3.11
BuyUS$875,74611 Dec 18
Adam Bierman
EntityIndividual
Role
Chief Executive Officer
Co-Founder
Shares342,660
Max PriceUS$2.56
BuyUS$857,37311 Dec 18
Andrew Modlin
EntityIndividual
Role
Member of the Board of Directors
Co-Founder
Shares335,815
Max PriceUS$2.55

Ownership Breakdown


Management Team

  • Jim Miller (58yo)

    Vice President of Accounting

    • Tenure: 0yrs
  • Michael Kramer (54yo)

    Chief Financial Officer

    • Tenure: 0.2yrs
  • David Dancer

    Chief Marketing Officer

    • Tenure: 0.6yrs
  • Adam Bierman (37yo)

    Co-Founder

    • Tenure: 1.1yrs
  • Andrew Modlin (31yo)

    Co-Founder

    • Tenure: 0.8yrs
  • Zeeshan Hyder

    Chief Corporate Development Officer

    • Tenure: 0yrs
  • Ben Cook (43yo)

    Chief Operating Officer

    • Tenure: 0.3yrs
  • Lisa Trager (52yo)

    General Counsel & Director

    • Tenure: 0.8yrs
  • Stéphanie Van Hassel

    Head of Investor Relations

    • Tenure: 0yrs
  • Daniel Yi

    Senior Vice President of Corporate Communications

    • Tenure: 0yrs

Board Members

  • Antonio Villaraigosa (65yo)

    Director

    • Tenure: 0.5yrs
  • Andy Rayburn (63yo)

    Director

    • Tenure: 0.8yrs
  • Mark Hutchison (65yo)

    Director

    • Tenure: 0.8yrs
  • Adam Bierman (37yo)

    Co-Founder

    • Tenure: 1.1yrs
  • Andrew Modlin (31yo)

    Co-Founder

    • Tenure: 0.8yrs
  • Ben Rose (44yo)

    Non-Executive Chairman

    • Tenure: 0.5yrs
  • Lisa Trager (52yo)

    General Counsel & Director

    • Tenure: 0.8yrs
  • Stacey Hallerman (55yo)

    Director

    • Tenure: 0.6yrs
  • Jay Brown (44yo)

    Director

    • Tenure: 0.6yrs

Company Information

MedMen Enterprises Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MedMen Enterprises Inc.
  • Ticker: 0JS
  • Exchange: BST
  • Founded:
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: CA$1.808b
  • Market Cap: CA$363.148m
  • Listing Market Cap: CA$1.209b
  • Shares outstanding: 498.95m
  • Website: https://www.medmen.com

Number of Employees


Location

  • MedMen Enterprises Inc.
  • 10115 Jefferson Boulevard
  • Culver City
  • California
  • 90232
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MMENCNSX (Canadian National Stock Exchange)YesClass B Subordinate Voting SharesCACADMay 2018
0JSBST (Boerse-Stuttgart)YesClass B Subordinate Voting SharesDEEURMay 2018
MMNF.FOTCPK (Pink Sheets LLC)YesClass B Subordinate Voting SharesUSUSDMay 2018

Biography

MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal canna ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/02/21 01:20
End of Day Share Price2018/11/23 00:00
Earnings2018/09/30
Annual Earnings2018/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

© 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. ALL RIGHTS RESERVED.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2018, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2018)